Neurology:早期检测可以预测脑卒中患者的上肢痉挛

2015-09-24 崔倩 译 MedSci原创

许多中风患者患有手臂痉挛,这能引起疼痛并使感觉功能受损。但也有方法可以提前识别这样的患者,使他们能够获得尽早治疗的方法。Sahlgrenska学院的研究人员在哥德堡地区已经完成了一项中风患者的研究。痉挛及相关并发症是常见于中风之后,导致关节活动度较差,一年后手臂会感觉到更大的痛苦并且不敏感。一项研究由哥德堡大学Sahlgrenska学院进行的研究,发现了Fugl-Meyer评估量表,即在中风后的第

许多中风患者患有手臂痉挛,这能引起疼痛并使感觉功能受损。但也有方法可以提前识别这样的患者,使他们能够获得尽早治疗的方法。Sahlgrenska学院的研究人员在哥德堡地区已经完成了一项中风患者的研究。

痉挛及相关并发症是常见于中风之后,导致关节活动度较差,一年后手臂会感觉到更大的痛苦并且不敏感。

一项研究由哥德堡大学Sahlgrenska学院进行的研究,发现了Fugl-Meyer评估量表,即在中风后的第一个月内进行的感觉测试,预测哪些患者会在一年内发生痉挛,具有相当高的准确程度。

共有117例哥德堡区的患者参加了这项研究,他们的平均年龄为67岁。所有这些人在第一次中风三天后,曾经历过手臂运动感觉功能较差。研究人员对这些患者的上肢感觉运动功能,痉挛和关节活动范围进行了其后一年的监测。

Arve Opheim,Sahlgrenska学院的研究员,说:“我们的研究结果表明,感觉功能的系统检查可以确定处于痉挛风险的患者,使他们能够得到早期治疗。减少疼痛、功能受损和其他的痉挛后果将不可避免地随之而来。”

原始出处:

A. Opheim, A. Danielsson, M. Alt Murphy, H. C. Persson, K. S. Sunnerhagen. Early prediction of long-term upper limb spasticity after stroke: Part of the SALGOT study,Neurology,2015.9.23

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1679065, encodeId=1f0316e9065e6, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sun Sep 27 11:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720059, encodeId=dc841e20059cc, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Thu Sep 01 22:40:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999565, encodeId=d25c1999565c4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Apr 26 05:40:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311737, encodeId=572b1311e37a2, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sat Sep 26 02:40:00 CST 2015, time=2015-09-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1679065, encodeId=1f0316e9065e6, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sun Sep 27 11:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720059, encodeId=dc841e20059cc, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Thu Sep 01 22:40:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999565, encodeId=d25c1999565c4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Apr 26 05:40:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311737, encodeId=572b1311e37a2, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sat Sep 26 02:40:00 CST 2015, time=2015-09-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1679065, encodeId=1f0316e9065e6, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sun Sep 27 11:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720059, encodeId=dc841e20059cc, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Thu Sep 01 22:40:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999565, encodeId=d25c1999565c4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Apr 26 05:40:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311737, encodeId=572b1311e37a2, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sat Sep 26 02:40:00 CST 2015, time=2015-09-26, status=1, ipAttribution=)]
    2016-04-26 yinhl1978
  4. [GetPortalCommentsPageByObjectIdResponse(id=1679065, encodeId=1f0316e9065e6, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sun Sep 27 11:40:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720059, encodeId=dc841e20059cc, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Thu Sep 01 22:40:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999565, encodeId=d25c1999565c4, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Apr 26 05:40:00 CST 2016, time=2016-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311737, encodeId=572b1311e37a2, content=<a href='/topic/show?id=624de11204a' target=_blank style='color:#2F92EE;'>#痉挛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71120, encryptionId=624de11204a, topicName=痉挛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dc7399, createdName=apoenzyme, createdTime=Sat Sep 26 02:40:00 CST 2015, time=2015-09-26, status=1, ipAttribution=)]
    2015-09-26 apoenzyme

相关资讯

霍勇:补充叶酸,预防脑卒中“新处方”

“中国患者在降压治疗同时补充叶酸,可显著降低首次卒中发作的风险。”在2015年中国脑卒中大会上,北京大学第一医院心内科及心脏中心主任、亚太介入心脏病学会秘书长霍勇发布了中国脑卒中一级预防研究(CSPPT)重大研究成果-- 在无心肌梗死及卒中病史的中国成人高血压患者中,依娜普利叶酸片为基础的降压治疗显著降低了21%的首次脑卒中风险,“即使是单纯补充叶酸,也有利于减少脑卒中乃至心脑血管疾病的发生率。”

中国急性缺血性脑卒中早期血管内介入诊疗指南——介入治疗适应证和禁忌证

Penumbra 试验是一项前瞻性、多中心研究, 研究目的是评估Penumbra 系统的安全性和有效性[ 20 ] 。该试验纳入发病3 h 内不适合静脉溶栓或静脉溶栓失败的缺血性脑卒中患者。结果显示: 闭塞血管达到部分或完全再通的比率为82%

流产者心梗和脑卒中风险均增加

     很多事情,如果用数字说话就会吓人一跳,比如流产。有数据表明,我国每年人工流产手术达1300万例,而其中超过六成为未婚女性。尤其在暑假期间,流产人数更是暴增。         无痛人流,睡一觉就好?街头广告常常这样说。事实上,流产并非广告中所言简单的事。除了出血、感染、人流不全、

Stroke:短时血压变异性对急性脑卒中预后的影响

血压变异性(BPV)可能是急性卒中预后的一个重要因素。该研究调查了现有的证据BPV对卒中后的影响结果,同时也考虑到了BPV测量技术和定义。按照预先指定的研究协议执行进行文献检索。两个审评员独立评估研究的合格性和质量。适合的研究被研究人员进行荟萃分析来评估BPV对不良功能结果的影响。研究人员从列入的1359篇引文中确定18项研究。其中的7项研究被列入了BPV对功能预后(死亡或残疾)的影响的荟萃分析。

点赞!中国脑卒中一级预防研究重大成果惊艳国际医疗界

H型高血压是最容易导致脑卒中(又称“中风”)的高血压,规范治疗H型高血压能显著降低发生脑卒中的风险。5月9日,在2015中国脑卒中大会上,健康界获悉,“中国脑卒中一级预防研究(CSPPT)”重大科研成果发布,即“低叶酸—高Hcy(同型半胱氨酸)—H型高血压—高卒中发生率”以及“含有叶酸的降压药—降压降低Hcy—更有效降低脑卒中风险”这一证据链得到双向验证。该研究显示,降压药辅以叶酸能更有效降低高血